Literature DB >> 2139358

The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon.

L M Pfeffer1, D B Donner.   

Abstract

Human lymphoblastoid cell lines (Daudi, Daudi subclones, Raji and MOLT-4) were compared for sensitivity to the antiproliferative action of alpha-interferon (IFN-alpha) and down-regulation of IFN-alpha receptors. IFN-sensitive and IFN-resistant cell lines have similar numbers (2-4000/cell) of high affinity (20-75 pM) IFN-alpha receptors. Treatment of IFN-sensitive cells with low concentrations (3-10 pM) of IFN-alpha results in low receptor occupancy and nearly complete (greater than 95%) down-regulation of cell surface IFN-alpha receptors within 5 h. Treatment of resistant cells with higher IFN concentrations (30 pM) only results in partial (approximately 60%) receptor down-regulation that is directly related to receptor occupancy. Receptor-receptor interactions, induced by IFN-alpha binding, may account for the enhanced down-regulation of IFN-alpha receptors in IFN-sensitive cells. Such interactions apparently do not occur in IFN-resistant lymphoblastoid cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139358

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Constitutive type I interferon modulates homeostatic balance through tonic signaling.

Authors:  Daniel J Gough; Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone; David E Levy
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

Review 2.  Interferons and their stimulated genes in the tumor microenvironment.

Authors:  Hyeonjoo Cheon; Ernest C Borden; George R Stark
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

3.  STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities.

Authors:  C H Yang; A Murti; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation.

Authors:  R Kumar; I Atlas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  Interferon alpha induces protein kinase C-epsilon (PKC-epsilon) gene expression and a 4.7-kb PKC-epsilon-related transcript.

Authors:  C Wang; S N Constantinescu; D J MacEwan; B Strulovici; L V Dekker; P J Parker; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents.

Authors:  Ziyun Du; Meiyun Fan; Jong-Gwan Kim; Dara Eckerle; Leonard Lothstein; Lai Wei; Lawrence M Pfeffer
Journal:  J Biol Chem       Date:  2009-08-17       Impact factor: 5.157

Review 7.  Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.

Authors:  Serge Y Fuchs
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

8.  Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.

Authors:  A X Delcayre; F Salas; S Mathur; K Kovats; M Lotz; W Lernhardt
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

9.  Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.

Authors:  Staley A Brod
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-14

10.  Type I interferon responses are impaired in latently HIV infected cells.

Authors:  Nischal Ranganath; Teslin S Sandstrom; Saleh Fadel; Sandra C Côté; Jonathan B Angel
Journal:  Retrovirology       Date:  2016-09-09       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.